05 August 2026
05 August 2026
SOPHiA GENETICS is tasked with developing its Solid Tumor application as a decentralised companion diagnostic.
The planned trial aims to enrol at least 15 participants and is expected to begin in the fourth quarter of 2026.
Chugai scientists will use Biomni Lab to consolidate diverse biomedical resources in a single digital workspace.
Completion of the deal is subject to shareholder and regulatory approvals and is anticipated by the end of the year.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
